Found: 2
Select item for more details and to access through your institution.
Targeting CBX3 with a Dual BET/PLK1 Inhibitor Enhances the Antitumor Efficacy of CDK4/6 Inhibitors in Prostate Cancer.
- Published in:
- Advanced Science, 2023, v. 10, n. 36, p. 1, doi. 10.1002/advs.202302368
- By:
- Publication type:
- Article
The Molecular Basis and Therapeutic Potential of Leukemia Inhibitory Factor in Cancer Cachexia.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2955, doi. 10.3390/cancers14122955
- By:
- Publication type:
- Article